Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The aims of this study are:
- to assess the impact of TOOKAD® Soluble-Vascular Targeted Photodynamic Therapy (VTP) on
the rate of absence of definite cancer using patients on active surveillance as a
comparison (co-primary objective A) and
- to determine the difference in rate of treatment failure associated with observed
progression of disease from low risk prostate cancer to moderate or higher risk prostate
cancer in men who undergo TOOKAD® Soluble-VTP compared to men on active surveillance
(co-primary objective B).